A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of ABT-335 in Combination With Atorvastatin and Ezetimibe to Atorvastatin in Combination With Ezetimibe in Subjects With Combined (Atherogenic) Dyslipidemia

Name: A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of ABT-335 in Combination With Atorvastatin and Ezetimibe to Atorvastatin in Combination With Ezetimibe in Subjects With Combined (Atherogenic) Dyslipidemia
Creator: Vivli
Published: 2024-12-04 16:00:09
License: 暂无描述

DataCite Commons2024-12-04 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/00003028/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

The primary purpose of this study is to compare the safety and efficacy of ABT-335 (investigational drug) coadministered with atorvastatin and ezetimibe to atorvastatin coadministered with ezetimibe in subjects with abnormal lipid (fat) levels in the blood.

提供机构：

Vivli

创建时间：

2018-10-27